RNAC Cartesian Therapeutics, Inc.: institutional ownership and insider trading
99 funds reported holding $97.2M of Cartesian Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $15.7M, with 24 new positions and 12 funds selling out; over the last 12 months insiders bought $206K and sold $259K on the open market.
Famous investors holding RNAC
- Izzy Englander (Millennium Management): $3.23M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.09M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $299K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $212K, 0.0% of the portfolio
Largest institutional holders of RNAC
- Squarepoint Ops LLC — $23.5M
- BlackRock, Inc. (BLK) — $8.54M
- 683 Capital Management, LLC — $6.77M
- VANGUARD CAPITAL MANAGEMENT LLC — $5.79M
- VANGUARD GROUP INC — $3.90M
- FMR LLC — $3.84M
- GEODE CAPITAL MANAGEMENT, LLC — $3.72M
- AQR CAPITAL MANAGEMENT LLC — $3.71M
- MILLENNIUM MANAGEMENT LLC — $3.23M
- TWO SIGMA INVESTMENTS, LP — $3.09M
Recent RNAC insider trades
- Jan 6, 2026: Davis Blaine sold 10,591 shares ($72.2K)
- Jan 6, 2026: Miljkovic Milos sold 3,573 shares ($24.4K)
- Jan 6, 2026: Brunn Carsten sold 23,766 shares ($162K)
- Dec 4, 2025: Barabe Timothy C bought 30,000 shares ($206K)
5%+ owners
- Barclays PLC: 6.0% (Schedule 13G, filed Aug 13, 2026)